Frontier Biotechnologies, Co., Ltd.
2Patents
1Active
2Granted
27Portfolio score
Filing activity: Sep 23, 2003 → Sep 25, 2009 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7575750B2 | Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity | Chemistry; Metallurgy | 1 | Expired |
| US8470527B2 | Method of inhibiting HIV-1 replication by administering modified GP41 C34 peptide derivatives with enhanced pharmacological properties | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.